Cancer Research and Treatment

Rajarshi Roy

1 Article

Palliative Radiotherapy in the Presence of Well-Controlled Metastatic Disease after Initial Chemotherapy May Prolong Survival in Patients with Metastatic Esophageal and Gastric Cancer: Mohan Hingorani, Sanjay Dixit, Miriam Johnson, Victoria Plested, Kevin Alty, Peter Colley, Andrew W. Beavis, Rajarshi Roy, Anthony Maraveyas; Cancer Res Treat. 2015;47(4):706-717. Published online February 16, 2015; DOI: https://doi.org/10.4143/crt.2014.174

Purpose
We report the outcomes of patients treated with palliative radiotherapy (pRT) to the primary tumour in the context of well-controlled metastatic disease after initial chemotherapy. Materials and Methods Clinical records of 132 patients with metastatic esophago-gastric (OG) cancer treated with palliative chemotherapy (pCT) between January 2009 and June 2013 were reviewed. Ninetyseven patients had responding or stable disease after 3 months of chemotherapy, of whom 53 patients received pRT to the primary tumour after initial chemotherapy in the presence of well-controlled metastatic disease (group A, pCT-RT). The remaining 44 patients were treated with pCT alone (group B, pCT). Treatment-related outcomes were assessed in above groups including time to local progression (TTLP), progression-free and overall survival.
Results
The median overall survival for patients treated with pRT after initial chemotherapy (group A) was 23.3 months (95% confidence interval [CI], 17.70 to 28.89 months) and significantly higher than the 14 months (95% CI, 10.91 to 17.08 months) in patients treated with pCT alone (group B) (p < 0.001). The use of pCT-RT was an independent predictor of OS in multivariate analysis. Local recurrence was observed in 12/53 of patients (23%) in group A compared to 16/44 (36%) in group B. The median TTLP was significantly higher in patients after pCT-RT at 17.3 months (5.23 months to 44.50 months) compared to 8.3 months (range, 4.10 to 25.23 months) in patients treated with pCT alone (p=0.006). Conclusion The possibility of pRT influencing systemic disease in advanced OG cancer has not been reported, and results from the present study present strong arguments for investigation of this therapeutic strategy in a randomized trial.

Citations

Citations to this article as recorded by

Reconsidering the Role of Radiotherapy for Inoperable Gastric Cancer: A Systematic Review of Gastric Radiotherapy Given With Definitive and Palliative Intent
A. Case, F. Williams, S. Prosser, H. Hutchings, T. Crosby, R. Adams, G. Jenkins, S. Gwynne
Clinical Oncology.2025; 37: 103693. CrossRef
Comparison of Efficacy and Safety of Combined Chemoimmunotherapy With or Without Radiation Therapy for Stage IVB Esophageal Squamous Cell Carcinoma: A Multicenter Propensity Score Matching Analysis
Biqi Chen, Wenyan Chen, Qi Cheng, Hao Zhang, Bingyi Wang, Yujin Xu, Chen Yang, Xingyuan Cheng, Ruixi Wang, Sifen Wang, Peiying Cen, Lin Wang, Mihnea P. Dragomir, Yujia Zhu, Shiliang Liu, Mian Xi, Qiaoqiao Li, Baoqing Chen
International Journal of Radiation Oncology*Biology*Physics.2024; 120(4): 1084. CrossRef
The value of intervention with radiotherapy after first-line chemo-immunotherapy in locally advanced or metastatic esophageal squamous cell carcinoma: A multi-center retrospective study
Hui-Hui Hu, Xin Xu, Xiao-Yang Li, Ya Zeng, Yue Li, Xin-Yun Song, Xiao-Long Fu, Xiu-Mei Ma, Wen Yu
Clinical and Translational Radiation Oncology.2024; 48: 100818. CrossRef
Oligometastatic esophageal cancer cured by systemic therapy combined with radiotherapy to primary tumor and metastasis (metastasis-directed therapy)—small case series
Mohan Hingorani, Hannah Stubley
Exploration of Targeted Anti-tumor Therapy.2024; 5(4): 921. CrossRef
The Contribution of Curative Dose Radiotherapy to Primary Disease with Concurrent Chemotherapy on Survival in Patients with Metastatic Esophageal Cancer
Menekşe Turna, Meltem Kırlı, Okan Özdemir, Hamit Başaran, Kadriye Ayşenur Arlı Karaçam
European Archives of Medical Research.2023; 39(2): 74. CrossRef
Induction immunochemotherapy followed by radiotherapy for patients with unresectable locally advanced or metastatic esophageal cancer: A propensity score-matched analysis
Wei Deng, Xiao Chang, Xin Dong, Yuting Zhao, Dan Yang, Leilei Jiang, Anhui Shi, Huiming Yu, Rong Yu, Zefen Xiao, Weihu Wang
International Immunopharmacology.2023; 124: 110955. CrossRef
Combine radiotherapy and immunotherapy in esophageal squamous cell carcinoma
Yicong Chen, Ruixuan Yu, Yongmei Liu
Critical Reviews in Oncology/Hematology.2023; 190: 104115. CrossRef
Metastasis pattern and prognosis in men with esophageal cancer patients
Shengqiang Zhang, Jida Guo, Hongyan Zhang, Huawei Li, Mohamed Osman Omar Hassan, Linyou Zhang
Medicine.2021; 100(25): e26496. CrossRef
A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Esophageal Cancer: A SEER-Based Study
Xin Tang, Xiaojuan Zhou, Yanying Li, Xue Tian, Yongsheng Wang, Meijuan Huang, Li Ren, Lin Zhou, Zhenyu Ding, Jiang Zhu, Yong Xu, Feng Peng, Jin Wang, You Lu, Youling Gong
Annals of Surgical Oncology.2019; 26(2): 321. CrossRef
Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach

Journal of Gastric Cancer.2019; 19(1): 1. CrossRef
A clinical analysis of systemic chemotherapy combined with radiotherapy for advanced gastric cancer
Hong-Min Dong, Qin Wang, Wen-Ling Wang, Gang Wang, Xiao-Kai Li, Guo-Dong Li, Juan Chen
Medicine.2018; 97(23): e10786. CrossRef
Palliative radiotherapy and chemoradiotherapy in stage IVA/B esophageal cancer patients with dysphagia
Terufumi Kawamoto, Keiji Nihei, Keisuke Sasai, Katsuyuki Karasawa
International Journal of Clinical Oncology.2018; 23(6): 1076. CrossRef
Improved Overall Survival with Aggressive Primary Tumor Radiotherapy for Patients with Metastatic Esophageal Cancer
David M. Guttmann, Nandita Mitra, Justin Bekelman, James M. Metz, John Plastaras, Weiwei Feng, Samuel Swisher-McClure
Journal of Thoracic Oncology.2017; 12(7): 1131. CrossRef
Lymph node dissection improved survival in patients with metastatic thoracic esophageal cancer: An analysis of 220 patients from the SEER database
San-Gang Wu, Zhen-Yu He, Yan Wang, Jia-Yuan Sun, Huan-Xin Lin, Guo-Qiang Su, Qun Li
International Journal of Surgery.2016; 35: 13. CrossRef
Expression of microtubule-associated protein TPX2 in human gastric carcinoma and its prognostic significance
Cuijie Shao, Changsheng Duan, Jiani Wang, Shunlian Luan, Yong Gao, Dan Jin, Deqiang Wang, Yuming Li, Lihua Xu
Cancer Cell International.2016;[Epub] CrossRef

11,935 View
84 Download
15 Web of Science
15 Crossref

Author index